Amersfoort, Netherlands

Arie Pieter Otte

This inventor holds 26 USPTO granted patents and 3 published patent applications, plus 10 CIPO patents and 14 EPO patents, primarily in Gene Expression Regulation. Top assignees: Chromagenics B.v., Cellagenics B.v.. Active years: 2007-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arie Pieter Otte. Retrieved from https://idiyas.com/inventor/arie-pieter-otte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 42.3


 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Expression
Nucleic Acid Fragments
Selectable Markers
Chromatin Openers
Protein Production
Transcription Factors
Host Cell Selection
Transcription Regulatory Sequences
Expression Augmentation
Vectors
DNA Fragments
Protein Expression
26 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arie Pieter Otte

Introduction

Arie Pieter Otte is a prominent inventor based in Amersfoort, Netherlands, known for his significant contributions to biotechnology. With an impressive portfolio of 26 patents, Otte has made remarkable strides in the field of gene expression and eukaryotic host cell development.

Latest Patents

Otte's latest innovations include groundbreaking patents that focus on intergenic elements and stringent selectable markers. One notable invention pertains to nucleic acid fragments and constructs that enhance gene expression by utilizing genomic sequences upstream of Rb1 and p15C. This invention enables the production of gene products of interest in mammalian host cells with the use of stringent selectable markers. Another significant patent involves nucleic acid constructs that comprise selectable marker genes in multicistronic transcription units, aimed at improving the generation and selection of eukaryotic host cells. These advancements highlight Otte's commitment to enhancing biotechnological applications.

Career Highlights

Throughout his career, Arie Pieter Otte has worked with esteemed companies such as Chromagenics B.V. and Cellagenics B.V. His work has not only contributed to the companies' advancements but has also significantly impacted the broader field of biotechnological research.

Collaborations

Otte has collaborated with notable professionals, including Arthur Leo Kruckeberg and Henricus Johannes Maria Van Blokland. These collaborations reflect his dedication to working alongside other experts in the field to innovate and expand the horizons of biotechnology.

Conclusion

Arie Pieter Otte's contributions to innovation in biotechnology through his patents and collaborations underscore his role as a vital figure in the industry. His work continues to influence the development of advanced gene expression techniques and the production of gene products in eukaryotic systems, paving the way for future research and advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…